Streamlined bioreactor-based production of human cartilage tissues

Area of Science:

• Biomedical Engineering
• Tissue Engineering
• Regenerative Medicine

Background:

• Traditional manual methods for engineered tissue grafts face regulatory and economic hurdles.
• Bioreactor systems offer a promising alternative for overcoming these limitations in clinical translation.

Purpose of the Study:

• To present an innovative, streamlined bioreactor manufacturing approach for engineering human cartilage tissue grafts.
• To bypass conventional 2D cell expansion and directly expand primary chondrocytes within a 3D scaffold in a perfusion bioreactor.

Main Methods:

• Freshly isolated human primary chondrocytes were seeded and expanded within a 3D scaffold in a perfusion bioreactor for 2 weeks.
• Chondrocytes underwent subsequent chondrogenic differentiation in the bioreactor for another 2 weeks.
• The process was scaled to produce clinically relevant cartilage graft sizes (50 mm diameter).

Main Results:

• Chondrocytes expanded in 3D scaffolds showed enhanced chondrogenic phenotype maintenance compared to 2D flask expansion (collagen type II mRNA, 18-fold; Sox-9, 11-fold).
• Engineered cartilage tissues derived from 3D-expanded chondrocytes exhibited superior cartilaginous properties.
• The bioreactor process successfully generated up-scaled cartilage grafts of clinical relevance.

Conclusions:

• This streamlined, bioreactor-based process facilitates efficient expansion and differentiation of chondrocytes for cartilage tissue engineering.
• The method offers a robust, scalable, and potentially cost-effective approach for manufacturing clinical-grade cartilage grafts.
• This approach supports the development of compact, closed bioreactor systems compliant with regulatory guidelines for future clinical applications.